Breast MR beats mammo, ultrasound for women with nipple discharge
In women with nipple discharge, contrast breast MR has higheroverall sensitivity for detecting malignant and high-risk lesionsthan mammography or ultrasound.
In women with nipple discharge, contrast breast MR has higher overall sensitivity for detecting malignant and high-risk lesions than mammography or ultrasound.
Between March 2007 and July 2009, 38 women with nipple discharge underwent ultrasound, mammography, and contrast MR (1.5T). A malignant lesion was found in five of 38 patients. A high-risk lesion was found in 14 of 38 patients. Contrast MR found all five of the cancers and 13 of the 14 high-risk lesions for a sensitivity of 94.74%. Mammography had a sensitivity of 26.32%; ultrasound had a sensitivity of 63.16%.
Contrast MR should be recommended when conventional imaging is negative, according to Dr. Michele Lorenzon, from the radiology department at the University of Udine in Italy. The study was presented at the European Congress of Radiology in Vienna in March.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
